-
Your prediction
Pros and Cons of Advanced Proteome Therapeutics in the next few years
Pros
Cons
Performance of Advanced Proteome Therapeutics vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Advanced Proteome Therapeutics | - | - | - | - | - | - | - |
| Northwest Biotherapeutics Inc. | 0.000% | -11.765% | 0.000% | -21.053% | -27.184% | -63.054% | -84.211% |
| Larimar Therapeutics Inc. | -1.690% | -6.452% | 1.754% | 9.434% | 4.819% | -4.918% | -70.256% |
| Achieve Life Sciences Inc. | -6.250% | 8.871% | 25.000% | 203.371% | 82.432% | 52.715% | 17.391% |
News
The Best Semiconductor Stock to Buy Isn't AMD or Qualcomm: It's Nvidia, and Our Data Proves It
The semiconductor industry is benefiting from the terrific demand for artificial intelligence (AI) chips. Nvidia (NASDAQ: NVDA) has been one of the biggest beneficiaries of the phenomenal growth in
Advanced Micro Devices vs. Arm Holdings: Comparing Revenue Trends Between These Artificial Intelligence Companies
Advanced Micro Devices (NASDAQ:AMD) generates revenue by developing specialized processors, graphics cards, and custom computing solutions for global manufacturers.
It introduced new server
AMD Has More Than Tripled Off Its Low and Still Trades 20% Below Its High
Advanced Micro Devices (NASDAQ:AMD) is having one of those years where two opposite descriptions of the stock are both accurate. Shares trade near $465 as of this writing. That is more than triple


